Healthcare Equities

The companies that provide, support or coordinate medical goods and services. This sector spans a broad range of activities – including the development and manufacture of medical equipment, pharmaceuticals and other treatments. Activities range from research to manufacturing, administration, insurance and facilities management. Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals and specialty pharmaceuticals.

KALA BIO (KALA)

Latest price

USD0.81

0.01 (1.26)
As at 27/10/2025
Market capitalisation
USD6m

LTR Pharma (LTP)

Latest price

AUD0.50

−0.03 (−5.66)
As at 27/10/2025
Market capitalisation
AUD60m
View equity

Medigene (MDG1)

Latest price

EUR0.13

−0.05 (−27.57)
As at 27/10/2025
Market capitalisation
View equity

Mendus (IMMU)

Latest price

SEK6.69

0.70 (11.69)
As at 27/10/2025
Market capitalisation
SEK312m
View equity

edison tv

Healthcare

Mendus – executive interview

Flash

Healthcare

Mendus — New strategy to include CML alongside AML

Update

Healthcare

Mendus — Steady progress throughout Q225

Newron Pharmaceuticals (NWRN)

Latest price

CHF13.82

−0.46 (−3.22)
As at 27/10/2025
Market capitalisation
CHF247m
View equity

Nykode Therapeutics (NYKD)

Latest price

NOK2.28

−0.07 (−3.06)
As at 27/10/2025
Market capitalisation
NOK768m
View equity

Ocugen (OCGN)

Latest price

USD1.56

−0.05 (−3.11)
As at 27/10/2025
Market capitalisation
USD456m
View equity

Okyo Pharma (OKYO)

Latest price

USD2.65

0.26 (10.88)
As at 27/10/2025
Market capitalisation
USD100m
View equity

Oncopeptides (ONCO)

Latest price

SEK5.23

−0.05 (−0.95)
As at 27/10/2025
Market capitalisation
SEK1,364m
View equity

OpGen (OPGN)

Latest price

0.00 (0.00)
As at 27/10/2025
Market capitalisation
View equity
Laboratory Opgen

Update

Healthcare

OpGen — Cash concerns dampen active Q2

Laboratory Opgen

Flash note

Healthcare

OpGen — FIND collaboration advances to development

Flash note

Healthcare

OpGen — Feasibility milestone from FIND collaboration

Oryzon Genomics (ORY)

Latest price

EUR3.32

0.12 (3.59)
As at 27/10/2025
Market capitalisation
EUR266m
View equity

OSE Immunotherapeutics (OSE)

Latest price

EUR5.98

−0.21 (−3.39)
As at 27/10/2025
Market capitalisation
EUR135m
View equity

Percheron Therapeutics (PER)

Latest price

AUD0.01

0.00 (0.00)
As at 27/10/2025
Market capitalisation
AUD10m
View equity

Recce Pharmaceuticals (RCE)

Latest price

AUD0.41

−0.01 (−2.41)
As at 27/10/2025
Market capitalisation
AUD121m
View equity

Saniona (SANION)

Latest price

SEK14.86

−1.00 (−6.31)
As at 27/10/2025
Market capitalisation
SEK2,190m
View equity

Santhera Pharmaceuticals (SANN)

Latest price

CHF10.60

0.50 (4.95)
As at 27/10/2025
Market capitalisation
CHF145m